XML 104 R88.htm IDEA: XBRL DOCUMENT v3.25.0.1
Accumulated Other Comprehensive Income (Loss) and Shareholders' Equity - Narrative (Details)
$ in Thousands
12 Months Ended
Dec. 28, 2024
USD ($)
hour
shares
Dec. 30, 2023
USD ($)
shares
Dec. 31, 2022
shares
Nov. 30, 2023
USD ($)
Dec. 30, 2017
shares
May 31, 2017
shares
Schedule of Shareholders' Equity [Line Items]            
Percent of incumbent board 0.75          
Term of employment agreement 2 years          
Common Stock            
Schedule of Shareholders' Equity [Line Items]            
Remaining authorized repurchase amount $ 167,600          
Certain officers            
Schedule of Shareholders' Equity [Line Items]            
Change in control percentage 20.00%          
Percent of board members 0.3333          
Term of employment agreement 2 years          
Number of times annual salary 200.00%          
Corporation's Chairman, President and CEO            
Schedule of Shareholders' Equity [Line Items]            
Number of times annual salary 300.00%          
Director plan            
Schedule of Shareholders' Equity [Line Items]            
Available for future issuance (in shares) | shares           300,000
Corporation common stock issued (shares) | shares 27,000 43,000 32,000      
Purchase Plan            
Schedule of Shareholders' Equity [Line Items]            
Available for future issuance (in shares) | shares         800,000  
Rights to purchase stock, minimum working hours per week | hour 20          
Rights to purchase stock, minimum working months per year 5 months          
Price of repurchased stock as percent of closing price on the exercise date 85.00%          
Maximum amount fair value for purchase of common stock $ 25          
Shares of common stock issued (shares) | shares 39,000 77,000 88,000      
Shares available for future issuance (shares) | shares 200,000          
Fair Value measurements on a recurring basis | Interest rate swap            
Schedule of Shareholders' Equity [Line Items]            
Derivative liability $ 1,500 $ 3,500        
Designated as Hedging Instrument | Fair Value measurements on a recurring basis | Interest rate swap            
Schedule of Shareholders' Equity [Line Items]            
Derivative liability 1,500          
Interest rate swap            
Schedule of Shareholders' Equity [Line Items]            
Change in derivative financial instruments, net of tax $ (1,100)          
Interest rate swap | Designated as Hedging Instrument            
Schedule of Shareholders' Equity [Line Items]            
Derivative, notional amount       $ 100,000    
Derivative, fixed interest rate       4.70%